Literature DB >> 24680863

Kidney protein profiling of Wilms' tumor patients by analysis of formalin-fixed paraffin-embedded tissue samples.

Elke Hammer1, Florian D Ernst2, Andrea Thiele3, Narasimha Kumar Karanam4, Christina Kujath5, Matthias Evert6, Uwe Völker7, Winfried Barthlen8.   

Abstract

UNLABELLED: Wilms' tumor (nephroblastoma, WT) is the most frequent renal cancer in children. However, molecular details leading to WT have not been characterized sufficiently yet. Proteomic studies might provide new insights but are hampered by limited availability of fresh frozen tissue specimen. Therefore, we tested formalin-fixed paraffin-embedded (FFPE) tissue sections routinely collected for pathological inspection for their use in in-depth-proteomic analyses of WT samples in comparison to fresh frozen specimen. The overlap of the proteins identified was over 65%. Thus we used FFPE material from 7 patients for tandem mass spectrometry based comparison of the proteomes of WT and healthy renal tissues. We detected 262 proteins, which were differentially expressed in tumor compared to healthy renal tissue. The majority of these proteins displayed lower levels in the tumor tissue and only 30% higher levels. For selected candidates data were confirmed by immunohistochemical staining. Correlation analysis of blastemal proportions in WT and protein intensities revealed candidates for tumor stratification.
CONCLUSION: This proof of principle proteomic study of FFPE tissue sections from WT patients demonstrates that these archived tissues constitute a valuable resource for larger in-depth proteomic studies to identify markers to follow chemotherapy efficiency or for stratification of tumor subtypes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FFPE; Formalin-fixed paraffin-embedded material; Nephroblastoma; Proteomics; Wilms' tumor

Mesh:

Substances:

Year:  2014        PMID: 24680863     DOI: 10.1016/j.cca.2014.03.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

Review 1.  Metabolic requirements of the nephron.

Authors:  Kasey Cargill; Sunder Sims-Lucas
Journal:  Pediatr Nephrol       Date:  2018-12-15       Impact factor: 3.714

2.  Peptide spectra in Wilms tumor that associate with adverse outcomes.

Authors:  Andrew Jackson Murphy; Janene Pierce; Erin H Seeley; Lisa M Sullivan; Eduardo D Ruchelli; Michael L Nance; Richard M Caprioli; Harold N Lovvorn
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

3.  Clinicohistological characteristics of renal cell carcinoma in children: A multicentre study.

Authors:  Jeong Ho Kim; Seong Il Seo; Cheryn Song; Jinsoo Chung; Cheol Kwak; Sung-Hoo Hong
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

Review 4.  Energy metabolism in neuroblastoma and Wilms tumor.

Authors:  Sepideh Aminzadeh; Silvia Vidali; Wolfgang Sperl; Barbara Kofler; René G Feichtinger
Journal:  Transl Pediatr       Date:  2015-01

5.  Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using Immunohistochemistry.

Authors:  Aditi Bagchi; Zachary Madaj; Kelly B Engel; Ping Guan; Daniel C Rohrer; Dana R Valley; Emily Wolfrum; Kristin Feenstra; Nancy Roche; Galen Hostetter; Helen M Moore; Scott D Jewell
Journal:  J Histochem Cytochem       Date:  2021-03-01       Impact factor: 2.479

6.  Protein Extraction From FFPE Kidney Tissue Samples: A Review of the Literature and Characterization of Techniques.

Authors:  Maria García-Vence; Maria Del Pilar Chantada-Vazquez; Ana Sosa-Fajardo; Rebeca Agra; Ana Barcia de la Iglesia; Alfonso Otero-Glez; Miguel García-González; José M Cameselle-Teijeiro; Cristina Nuñez; Juan J Bravo; Susana B Bravo
Journal:  Front Med (Lausanne)       Date:  2021-05-13

7.  Proteomic analysis of neurons microdissected from formalin-fixed, paraffin-embedded Alzheimer's disease brain tissue.

Authors:  Eleanor S Drummond; Shruti Nayak; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.